The impact of early intensive therapy on event-free survival (EFS) in children with acute myeloid leukemia (AML)
- PMID: 1578941
The impact of early intensive therapy on event-free survival (EFS) in children with acute myeloid leukemia (AML)
Similar articles
-
Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.N Engl J Med. 1996 May 30;334(22):1428-34. doi: 10.1056/NEJM199605303342203. N Engl J Med. 1996. PMID: 8618581 Clinical Trial.
-
Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.Pediatr Blood Cancer. 2007 Aug;49(2):127-32. doi: 10.1002/pbc.20944. Pediatr Blood Cancer. 2007. PMID: 16807916 Clinical Trial.
-
[Improved treatment results in children with AML: Results of study AML-BFM 93].Klin Padiatr. 2001 Jul-Aug;213(4):175-85. doi: 10.1055/s-2001-16849. Klin Padiatr. 2001. PMID: 11528551 Clinical Trial. German.
-
Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.Hematol Oncol Clin North Am. 1993 Feb;7(1):47-64. Hematol Oncol Clin North Am. 1993. PMID: 8449864 Review.
-
Therapy of acute myeloid leukemia in children.Leukemia. 1992;6 Suppl 2:31-5. Leukemia. 1992. PMID: 1578938 Review.
Cited by
-
Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.Cochrane Database Syst Rev. 2014 Sep 4;2014(9):CD006647. doi: 10.1002/14651858.CD006647.pub4. Cochrane Database Syst Rev. 2014. PMID: 25188452 Free PMC article.